Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis

Published:2016-07-15 Issue:10 Volume:30 Page:1979-1986
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Merlini G,Lousada I,Ando Y,Dispenzieri A,Gertz M A,Grogan M,Maurer M S,Sanchorawala V,Wechalekar A,Palladini G,Comenzo R L

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2016191.pdf

Reference69 articles.

1. Merlini G, Seldin DC, Gertz MA . Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011; 29: 1924–1933.

2. Merlini G, Wechalekar AD, Palladini G . Systemic light chain amyloidosis: an update for treating physicians. Blood 2013; 121: 5124–5130.

3. Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O'Fallon WM et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992; 79: 1817–1822.

4. Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD et al. Systemic amyloidosis in England: an epidemiological study. Br J Haematol 2013; 161: 525–532.

5. Merlini G, Palladini G . Light chain amyloidosis: the heart of the problem. Haematologica 2013; 98: 1492–1495.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver stiffness as a prognostic parameter and tool for risk stratification in advanced cardiac transthyretin amyloidosis;Clinical Research in Cardiology;2024-08-20

2. Autologous stem cell transplantation in AL amyloidosis: Muddy waters;Blood Reviews;2024-08

3. Successes in translation;Amyloid;2024-07-02

4. Влияние поражения сердца на прогноз у пациентов с системным AL-амилоидозом;Clinical Oncohematology;2024-07-01

5. Systemic Light Chain Amyloidosis;New England Journal of Medicine;2024-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3